Authors:
ANDREN PE
EMMETT MR
DAGUE BB
STEULET AF
WALDMEIER P
CAPRIOLI RM
Citation: Pe. Andren et al., BLOOD-BRAIN-BARRIER PENETRATION OF 3-AMINOPROPYL-N-BUTYLPHOSPHINIC ACID (CGP-36742) IN RAT-BRAIN BY MICRODIALYSIS MASS-SPECTROMETRY, Journal of mass spectrometry., 33(3), 1998, pp. 281-287
Authors:
STEULET AF
MOBIUS HJ
MICKEL SJ
STOCKLIN K
WALDMEIER PC
Citation: Af. Steulet et al., DETERMINATION OF RAT-BRAIN AND PLASMA-LEVELS OF THE ORALLY-ACTIVE GABA(B) ANTAGONIST 3-AMINO-PROPYL-N-BUTYL-PHOSPHINIC ACID (CG-36742) BY ANEW GC MS METHOD/, Biochemical pharmacology, 51(5), 1996, pp. 613-619
Authors:
STEULET AF
STOCKLIN K
WICKI P
WALDMEIER P
Citation: Af. Steulet et al., EFFECTS OF CGP-28014 ON THE IN-VIVO RELEASE AND METABOLISM OF DOPAMINE IN THE RAT STRIATUM ASSESSED BY BRAIN MICRODIALYSIS, Neurochemical research, 18(11), 1993, pp. 1131-1136
Citation: Pc. Waldmeier et al., INHIBITION OF CATECHOL-O-METHYLTRANSFERASE (COMT) AS WELL AS TYROSINEAND TRYPTOPHAN-HYDROXYLASE BY THE ORALLY-ACTIVE IRON CHELATOR, 1,2-DIMETHYL-3-HYDROXYPYRIDIN-4-ONE (L1, CP20), IN RAT-BRAIN IN-VIVO, Biochemical pharmacology, 45(12), 1993, pp. 2417-2424